Inventor
ZIMMERMANN KURT
US38 patents
⚠️ This page may combine multiple inventors who share the name “ZIMMERMANN KURT”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BRISTOL MYERS SQUIBB CO
14 patentsUS9273057B2Mar 1, 2016
Imidazotriazinecarbonitriles useful as kinase inhibitors
BRISTOL MYERS SQUIBB CO29 citations93
US7534792B2May 19, 2009
Pyrrolotriazine kinase inhibitors
BRISTOL MYERS SQUIBB CO30 citations92
US7223757B2May 29, 2007
Tyrosine kinase inhibitors
BRISTOL MYERS SQUIBB CO16 citations91
US7879855B2Feb 1, 2011
Pyrrolotriazine kinase inhibitors
BRISTOL MYERS SQUIBB CO10 citations83
US9556178B2Jan 31, 2017
Imidazotriazinecarbonitriles useful as kinase inhibitors
BRISTOL MYERS SQUIBB CO3 citations72
US7081454B2Jul 25, 2006
Tyrosine kinase inhibitors
BRISTOL MYERS SQUIBB CO6 citations72
US8940736B2Jan 27, 2015
Imidazotriazinecarbonitriles useful as kinase inhibitors
BRISTOL MYERS SQUIBB CO3 citations62
US7189716B2Mar 13, 2007
Tyrosine kinase inhibitors
BRISTOL MYERS SQUIBB CO4 citations62
US10550125B2Feb 4, 2020
Prodrugs of imidazotriazine compounds as CK2 inhibitors
BRISTOL MYERS SQUIBB CO0 citations51
US8343999B2Jan 1, 2013
Thiazolyl compounds useful as kinase inhibitors
BRISTOL MYERS SQUIBB CO1 citations51
US7470696B2Dec 30, 2008
Tyrosine kinase inhibitors
BRISTOL MYERS SQUIBB CO1 citations51
US6686385B2Feb 3, 2004
Anhydro sugar derivatives of indolocarbazoles
BRISTOL MYERS SQUIBB CO1 citations49
US6610727B2Aug 26, 2003
Anhydro sugar derivatives of indolocarbazoles
BRISTOL MYERS SQUIBB CO1 citations49
US6855698B2Feb 15, 2005
Topoisomerase I selective cytotoxic sugar derivatives of indolopyrrolocarbazoles
BRISTOL MYERS SQUIBB CO1 citations47
ARVINAS OPERATIONS INC
9 patentsUS11236051B2Feb 1, 2022
Compounds and methods for the targeted degradation of androgen receptor
ARVINAS OPERATIONS INC9 citations94
US11964945B2Apr 23, 2024
Compounds and methods for the targeted degradation of androgen receptor
ARVINAS OPERATIONS INC2 citations73
US11427548B2Aug 30, 2022
Compounds and methods for the targeted degradation of androgen receptor
ARVINAS OPERATIONS INC2 citations72
US10994015B2May 4, 2021
EGFR proteolysis targeting chimeric molecules and associated methods of use
ARVINAS OPERATIONS INC3 citations72
US11986531B2May 21, 2024
Compounds and methods for the targeted degradation of rapidly accelerated fibrosarcoma polypeptides
ARVINAS OPERATIONS INC0 citations62
US12264157B2Apr 1, 2025
Compounds and methods for the enhanced degradation of targeted proteins
ARVINAS OPERATIONS INC0 citations61
US11512083B2Nov 29, 2022
Compounds and methods for the enhanced degradation of targeted proteins
ARVINAS OPERATIONS INC1 citations61
US12441708B2Oct 14, 2025
Cereblon ligands and bifunctional compounds comprising the same
ARVINAS OPERATIONS INC0 citations52
US12569464B2Mar 10, 2026
Protein-protein interaction inducing technology
ARVINAS OPERATIONS INC0 citations46
BOSCH GMBH ROBERT
5 patentsUS4827173AMay 2, 1989
Commutator motor, especially a small motor for motor vehicles
BOSCH GMBH ROBERT31 citations90
US4748358AMay 31, 1988
Electric starter motor with holder for permanent magnets
BOSCH GMBH ROBERT22 citations76
US4445059AApr 24, 1984
Electric motor, in particular a small motor
BOSCH GMBH ROBERT11 citations73
US4542314ASep 17, 1985
Permanent-magnet commutator motor with auxiliary pole/bracket
BOSCH GMBH ROBERT17 citations71
US3951122AApr 20, 1976
Ignition system for internal combustion engine and method to generate ignition pulses
BOSCH GMBH ROBERT1 citations52